<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Posterior model choice in CRM • trialr</title>
<!-- jquery --><script src="https://code.jquery.com/jquery-3.1.0.min.js" integrity="sha384-nrOSfDHtoPMzJHjVTdCopGqIqeYETSXhZDFyniQ8ZHcVy08QesyHcnOUpMpqnmWq" crossorigin="anonymous"></script><!-- Bootstrap --><link href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script><!-- Font Awesome icons --><link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-T8Gy5hrqNKT+hzMclPo118YTQO6cYprQmhrYwIiQ/3axmI1hQomh7Ud2hPOy8SP1" crossorigin="anonymous">
<!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../jquery.sticky-kit.min.js"></script><script src="../pkgdown.js"></script><!-- mathjax --><script src="https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <div class="container template-vignette">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="../index.html">trialr</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/BEBOP.html">BEBOP in PePS2</a>
    </li>
    <li>
      <a href="../articles/CRM-model-choice.html">Posterior model choice in CRM</a>
    </li>
    <li>
      <a href="../articles/CRM-visualisation.html">Visualisation with CRM in `trialr`</a>
    </li>
    <li>
      <a href="../articles/CRM.html">Continual Reassessment Method in `trialr`</a>
    </li>
    <li>
      <a href="../articles/EffTox.html">EffTox in trialr</a>
    </li>
    <li>
      <a href="../articles/HierarchicalBayesianResponse.html">Hierarchical Bayesian Model for Binary Responses</a>
    </li>
    <li>
      <a href="../articles/trialr-overview.html">Overview of `trialr`</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">News</a>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/brockk/trialr">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->

      
      </header><div class="row">
  <div class="col-md-9">
    <div class="page-header toc-ignore">
      <h1>Posterior model choice in CRM</h1>
                        <h4 class="author">Kristian Brock</h4>
            
            <h4 class="date">2018-03-17</h4>
          </div>

    
    
<div class="contents">
<p>In the <a href="https://brockk.github.io/trialr/articles/CRM.html">introductory vignette</a>, we learned about the different variants of the CRM model implemented in <code>trialr</code>. Typically, the trialists choose a model implementation at the start of the trial and stick with it throughout. Some have preferred a two-parameter logit model over the one-parameter logit and empiric models because of the flexibility arising from the extra parameter. However, the inventor of the CRM has expressed his preference for the one-parameter models (citation needed).</p>
<p>The <a href="https://cran.r-project.org/web/packages/loo/index.html"><code>loo</code> package</a> by Vehtari, Gelman, Gabry, Piironen &amp; Goodrich and accompanying publication <span class="citation">Vehtari, Gelman, and Gabry (2016)</span>, provides approximate leave-one-out cross-validation (LOO) using Pareto smoothed importance sampling. This allows objective choice between competing Bayesian models via the <em>leave-one-out information criterion</em> (LOOIC). The different implementations of CRM in <code>trialr</code> each support the <code>loo</code> package. The result is that analysts can choose between the CRM variants at</p>
<div id="model-choice-by-looic" class="section level2">
<h2 class="hasAnchor">
<a href="#model-choice-by-looic" class="anchor"></a>Model choice by LOOIC</h2>
<p>Let us assume that our prior dose-toxicity skeleton and target toxicity rate are:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">skeleton &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="fl">0.05</span>, <span class="fl">0.1</span>, <span class="fl">0.15</span>, <span class="fl">0.33</span>, <span class="fl">0.5</span>)
target &lt;-<span class="st"> </span><span class="fl">0.33</span></code></pre></div>
<p>For the purposes of illustration, we assume we have dosed the following patients and observed the following outcomes:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">dose &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">1</span>, <span class="dv">2</span>,<span class="dv">2</span>,<span class="dv">2</span>,<span class="dv">2</span>,<span class="dv">2</span>,<span class="dv">2</span>,<span class="dv">2</span>,<span class="dv">2</span>, <span class="dv">3</span>,<span class="dv">3</span>,<span class="dv">3</span>,<span class="dv">3</span>,<span class="dv">3</span>, <span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>, <span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>,<span class="dv">5</span>)
tox  &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>, <span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">0</span>, <span class="dv">0</span>,<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">0</span>, <span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">1</span>,<span class="dv">1</span>, <span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">1</span>,<span class="dv">0</span>,<span class="dv">0</span>,<span class="dv">1</span>)</code></pre></div>
<p>These outcomes were simulated according to the assumed true dose-toxicity curve <code>c(0.1, 0.12, 0.15, 0.37, 0.71)</code>. They convey the types of outcome that may be observed if many patients are tested at each dose. Thus, in this example, the dose-toxicity curve is relatviely well-informed at each point. These values were not chosen to represent the distribution of doses that we tend to observe in dose-finding trials, where lower doses tend to be selected most often. The way the true curve is fairly flat over the first three doses and then steepens sharply, suggests that a two-parameter model might perform better than a one-parameter model.</p>
<p>We can fit the one- and two-parameter logit models to these data. We re-use the same prior on <span class="math inline">\(\beta\)</span> and use a <span class="math inline">\(N(0, 1)\)</span> prior on <span class="math inline">\(\alpha\)</span> in the two-parameter model.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(trialr)

dat1 &lt;-<span class="st"> </span><span class="kw">list</span>(
  <span class="dt">a0 =</span> <span class="dv">3</span>,
  <span class="dt">beta_mean =</span> <span class="dv">0</span>,
  <span class="dt">beta_sd =</span> <span class="kw">sqrt</span>(<span class="fl">1.34</span>),
  <span class="dt">num_doses =</span> <span class="kw">length</span>(skeleton),
  <span class="dt">skeleton =</span> skeleton,
  <span class="dt">num_patients =</span> <span class="kw">length</span>(dose),
  <span class="dt">tox =</span> tox,
  <span class="dt">doses =</span> dose
)
samp1 &lt;-<span class="st"> </span>rstan<span class="op">::</span><span class="kw"><a href="http://www.rdocumentation.org/packages/rstan/topics/stanmodel-method-sampling">sampling</a></span>(stanmodels<span class="op">$</span>CrmEmpiricNormalPrior,
                         <span class="dt">data =</span> dat1, <span class="dt">seed =</span> <span class="dv">123</span>)
dat2 &lt;-<span class="st"> </span><span class="kw">list</span>(<span class="dt">alpha_mean =</span> <span class="dv">0</span>,
             <span class="dt">alpha_sd =</span> <span class="dv">1</span>,
             <span class="dt">beta_mean =</span> <span class="dv">0</span>,
             <span class="dt">beta_sd =</span> <span class="kw">sqrt</span>(<span class="fl">1.34</span>),
             <span class="dt">num_doses =</span> <span class="kw">length</span>(skeleton),
             <span class="dt">skeleton =</span> skeleton,
             <span class="dt">num_patients =</span> <span class="kw">length</span>(dose),
             <span class="dt">tox =</span> tox,
             <span class="dt">doses =</span> dose
)
samp2 &lt;-<span class="st"> </span>rstan<span class="op">::</span><span class="kw"><a href="http://www.rdocumentation.org/packages/rstan/topics/stanmodel-method-sampling">sampling</a></span>(stanmodels<span class="op">$</span>CrmTwoParamLogisticNormalPrior,
                         <span class="dt">data =</span> dat2, <span class="dt">seed =</span> <span class="dv">123</span>)</code></pre></div>
<p>We must first extract the log-likelihood from each sample A function to do this is provided in <code>loo</code>:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(loo)
lik1 &lt;-<span class="st"> </span><span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/extract_log_lik">extract_log_lik</a></span>(samp1)
lik2 &lt;-<span class="st"> </span><span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/extract_log_lik">extract_log_lik</a></span>(samp2)</code></pre></div>
<p>We can then calculate the LOOIC of each model separately:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/loo">loo</a></span>(lik1)
<span class="co">#&gt; Computed from 4000 by 37 log-likelihood matrix</span>
<span class="co">#&gt; </span>
<span class="co">#&gt;          Estimate  SE</span>
<span class="co">#&gt; elpd_loo    -22.8 2.4</span>
<span class="co">#&gt; p_loo         1.0 0.2</span>
<span class="co">#&gt; looic        45.6 4.8</span>
<span class="co">#&gt; </span>
<span class="co">#&gt; All Pareto k estimates are good (k &lt; 0.5)</span>
<span class="co">#&gt; See help('pareto-k-diagnostic') for details.</span>
<span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/loo">loo</a></span>(lik2)
<span class="co">#&gt; Computed from 4000 by 37 log-likelihood matrix</span>
<span class="co">#&gt; </span>
<span class="co">#&gt;          Estimate  SE</span>
<span class="co">#&gt; elpd_loo    -23.6 2.4</span>
<span class="co">#&gt; p_loo         1.7 0.3</span>
<span class="co">#&gt; looic        47.2 4.8</span>
<span class="co">#&gt; </span>
<span class="co">#&gt; All Pareto k estimates are good (k &lt; 0.5)</span>
<span class="co">#&gt; See help('pareto-k-diagnostic') for details.</span></code></pre></div>
<p>We see that the one-parameter model has a lower LOOIC value, suggesting it <em>asks less of the data</em>. A byproduct of the method used by <code>loo</code> is approximate estimates of the standard errors. We can compare the models to see if the difference in fit is material given the estimate of the standard errors:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/compare">compare</a></span>(<span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/loo">loo</a></span>(lik1), <span class="kw"><a href="http://www.rdocumentation.org/packages/loo/topics/loo">loo</a></span>(lik2))
<span class="co">#&gt; elpd_diff        se </span>
<span class="co">#&gt;      -0.8       0.2</span></code></pre></div>
<p>The difference in expected log pointwise predictive density (elpd) is relatively large compared to the estimated standard error. We conclude that the extra parameter in the two-parameter model does not provide commensurate predictive performance and that the one-parameter model should be preferred. Some graphics will help to illuminate why.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(magrittr)
<span class="kw">library</span>(ggplot2)

truth &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="fl">0.1</span>, <span class="fl">0.12</span>, <span class="fl">0.15</span>, <span class="fl">0.37</span>, <span class="fl">0.71</span>)
df &lt;-<span class="st"> </span><span class="kw">data.frame</span>(
  <span class="dt">ProbTox =</span> <span class="kw">c</span>(
    truth,
    skeleton,
    samp1 <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">as.data.frame</span>(<span class="st">'prob_tox'</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">colMeans</span>(),
    samp2 <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">as.data.frame</span>(<span class="st">'prob_tox'</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">colMeans</span>()
  ),
  <span class="dt">DoseLevel =</span> <span class="kw">rep</span>(<span class="dv">1</span><span class="op">:</span><span class="kw">length</span>(skeleton), <span class="dt">times =</span> <span class="dv">4</span>),
  <span class="dt">Series =</span> <span class="kw">rep</span>(<span class="kw">c</span>(<span class="st">'Truth'</span>, <span class="st">'Skeleton'</span>, <span class="st">'Logit1'</span>, <span class="st">'Logit2'</span>), <span class="dt">each =</span> <span class="kw">length</span>(skeleton))
)
<span class="kw"><a href="http://www.rdocumentation.org/packages/ggplot2/topics/ggplot">ggplot</a></span>(df, <span class="kw"><a href="http://www.rdocumentation.org/packages/ggplot2/topics/aes">aes</a></span>(<span class="dt">x =</span> DoseLevel, <span class="dt">y =</span> ProbTox, <span class="dt">group =</span> Series, <span class="dt">col =</span> Series)) <span class="op">+</span>
<span class="st">  </span><span class="kw"><a href="http://www.rdocumentation.org/packages/ggplot2/topics/geom_point">geom_point</a></span>(<span class="dt">size =</span> <span class="dv">2</span>) <span class="op">+</span><span class="st"> </span><span class="kw"><a href="http://www.rdocumentation.org/packages/ggplot2/topics/geom_path">geom_line</a></span>(<span class="dt">size =</span> <span class="fl">1.2</span>) <span class="op">+</span><span class="st"> </span>
<span class="st">  </span><span class="kw"><a href="http://www.rdocumentation.org/packages/ggplot2/topics/labs">labs</a></span>(<span class="dt">title =</span> <span class="st">'Posterior Prob(Tox) using two competing models'</span>,
       <span class="dt">subtitle =</span> <span class="st">'Compared to prior skeleton and an assumed true dose-tox curve'</span>)</code></pre></div>
<p><img src="CRM-model-choice_files/figure-html/unnamed-chunk-7-1.png" width="672"></p>
<p>The true curve is more convex than that anticipated by the skeleton. To a great extent, this is reflected in each of the posterior estimated curves. Despite the extra parameter, the two parameter model does not show extra propensity to achieve a convex posterior curve. As such, the comparison of predictive performance concludes that the more complex model does not provide sufficient improvement and that the simpler model should be preferred.</p>
</div>
<div id="discussion" class="section level2">
<h2 class="hasAnchor">
<a href="#discussion" class="anchor"></a>Discussion</h2>
<p>CRM models are used to conduct dose-finding clinical trials. It is far from <em>the done thing</em> to switch analytical model mid-trial. But we lose nothing by asking “why not switch?” The CRM is probably the most frequently used <em>adaptive</em> clinical trial design. Adaptive trials in general are much lauded for the benefits they offer by reacting to results observed mid-trial. Why would we advocate changing various aspects of a trial and not contemplate changing the model, especially when the data observed favour a different model? The combination of the <code>trialr</code> and <code>loo</code> packages make it possible to select amongst models in an objective way. However, analysts should be aware of Vehtari’s view (<a href="https://github.com/avehtari/modelselection_tutorial">given in an online tutorial</a>) that cross-validaiton is useful when we don’t trust the model, or the model is complex with posterior dependencies. Neither seems particularly true of the models used in dose-finding clinical trials.</p>
</div>
<div id="other-crm-vignettes" class="section level2">
<h2 class="hasAnchor">
<a href="#other-crm-vignettes" class="anchor"></a>Other CRM vignettes</h2>
<p>There are many vignettes illuminating the CRM in <code>trialr</code>:</p>
<ul>
<li><a href="https://brockk.github.io/trialr/articles/CRM.html">An introduction to CRM in ‘trialr’</a></li>
<li><a href="https://brockk.github.io/trialr/articles/CRM-visualisation.html">Visualisation in CRM</a></li>
<li><a href="https://brockk.github.io/trialr/articles/CRM-model-choice.html">Posterior model choice</a></li>
<li>Stopping in CRM</li>
<li>Case study using Levy, et al. (2006)</li>
<li>Simulation</li>
</ul>
</div>
<div id="references" class="section level1 unnumbered">
<h1 class="hasAnchor">
<a href="#references" class="anchor"></a>References</h1>
<div id="refs" class="references">
<div id="ref-Vehtari2016">
<p>Vehtari, Aki, Andrew Gelman, and Jonah Gabry. 2016. “Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC.” <em>Statistics and Computing</em>, no. September: 1–20. doi:<a href="https://doi.org/10.1007/s11222-016-9696-4">10.1007/s11222-016-9696-4</a>.</p>
</div>
</div>
</div>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
        <div id="tocnav">
      <h2 class="hasAnchor">
<a href="#tocnav" class="anchor"></a>Contents</h2>
      <ul class="nav nav-pills nav-stacked">
<li><a href="#model-choice-by-looic">Model choice by LOOIC</a></li>
      <li><a href="#discussion">Discussion</a></li>
      <li><a href="#other-crm-vignettes">Other CRM vignettes</a></li>
      <li><a href="#references">References</a></li>
      </ul>
</div>
      </div>

</div>


      <footer><div class="copyright">
  <p>Developed by Kristian Brock.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="http://pkgdown.r-lib.org/">pkgdown</a>.</p>
</div>

      </footer>
</div>

  </body>
</html>
